Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
Abstract Background Despite the various strategies undertaken in the clinical practice, the mortality rate due to antibiotic-resistant microbes has been markedly increasing worldwide. In addition to multidrug-resistant (MDR) microbes, the "ESKAPE" bacteria are also emerging. Of course, the...
Saved in:
Main Authors: | Ramalingam Peraman (Author), Sathish Kumar Sure (Author), V. N. Azger Dusthackeer (Author), Naresh Babu Chilamakuru (Author), Padmanabha Reddy Yiragamreddy (Author), Chiranjeevi Pokuri (Author), Vinay Kumar Kutagulla (Author), Santhivardhan Chinni (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extrapulmonary Tuberculosis-An Update on the Diagnosis, Treatment and Drug Resistance
by: Radha Gopalaswamy, et al.
Published: (2021) -
Adenylosuccinic Acid: An Orphan Drug with Untapped Potential
by: Emma Rybalka, et al.
Published: (2023) -
Machine learning empowered drug discovery
by: Thirumoorthy Durai Ananda Kumar, et al.
Published: (2022) -
A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drug
by: E. Bhargav, et al.
Published: (2020) -
Drug Discovery
Published: (2013)